Australia markets close in 3 hours 13 minutes

Q BioMed Inc. (QBIO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.4825+0.0274 (+6.03%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.4550
Open0.4800
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.4210 - 0.4950
52-week range0.2650 - 1.5900
Volume13,175
Avg. volume80,500
Market cap13.799M
Beta (5Y monthly)1.70
PE ratio (TTM)N/A
EPS (TTM)-0.3970
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.00
  • PR Newswire

    Q BioMed Shows Significant Uptrend in Revenues in Year-End Update

    Q BioMed Inc. (OTCQB: QBIO), a commercial-stage biotech company, provides this update to shareholders with positive trend in revenues, advancement in pipeline assets and imminent uplisting to Nasdaq.

  • PR Newswire

    Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership

    Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, today announced it has engaged EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, to immediately support the commercialization of Strontium89, an FDA-approved cancer bone palliation radiotherapy.

  • PR Newswire

    Q BioMed Inc. Provides Shareholder Update

    Q BioMed Inc. (OTCQB: QBIO), a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector is pleased to provide an update to its shareholders.